Next Article in Journal
Mycobiome and Cancer: What Is the Evidence?
Next Article in Special Issue
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
Previous Article in Journal
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
Previous Article in Special Issue
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
 
 
Review

Article Versions Notes

Cancers 2021, 13(13), 3148; https://doi.org/10.3390/cancers13133148
Action Date Notes Link
article xml file uploaded 24 June 2021 05:37 CEST Original file -
article xml uploaded. 24 June 2021 05:37 CEST Update https://www.mdpi.com/2072-6694/13/13/3148/xml
article pdf uploaded. 24 June 2021 05:37 CEST Version of Record https://www.mdpi.com/2072-6694/13/13/3148/pdf
article html file updated 24 June 2021 05:38 CEST Original file -
article html file updated 27 July 2022 01:41 CEST Update https://www.mdpi.com/2072-6694/13/13/3148/html
Back to TopTop